Skip to main content

Advertisement

Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study

Fig. 3

a Event-free time, proportion of patients without new vascular lesions on different treatment. TNF inhibitor treatment included either infliximab (27 patients) or etanercept (5 patients) +/- disease-modifying antirheumatic drugs (DMARDs) and prednisolone. DMARD treatment included methotrexate or azathioprine + prednisolone, total 40 patients. Prednisolone monotherapy, 15 patients. *Comparison of the proportion of patients event-free in different treatment arms (chi-square test) after 5 years follow up. b Disease activity at the last visit. NIH (National Institutes of Health) disease activity score

Back to article page